Adlarity 10 mg/day transdermal system Images
Generic Name: donepezil
This medication has been identified as Adlarity 10 mg/day transdermal system. It is supplied by Corium, LLC.
Adlarity is used in the treatment of Alzheimer's Disease and belongs to the drug class cholinesterase inhibitors. Risk cannot be ruled out during pregnancy. Adlarity 10 mg/day transdermal system is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Adlarity
- Generic Name
- donepezil
- Strength
- 10 mg/day transdermal system
- Availability
- Prescription only
- Drug Class
- Cholinesterase inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Corium, LLC
- National Drug Code (NDC)
- 65038-0056
See also:
Namenda
Namenda is used to treat dementia associated with Alzheimer's disease. Learn about side effects ...
Exelon
Exelon (rivastigmine) is used to treat dementia caused by Alzheimer's or Parkinson's disease ...
Aricept
Aricept is used to treat mild to severe dementia caused by Alzheimer's disease. Learn about side ...
Leqembi
Leqembi (lecanemab) is used to treat Alzheimer’s disease to help slow the progression of dementia s ...
Namzaric
Namzaric (memantine/donepezil) is used to treat Alzheimer's Disease. Includes Namzaric side ...
Kisunla
Kisunla (donanemab) is used to treat Alzheimer’s disease to help slow down the decline in memory, t ...
Razadyne
Razadyne information from Drugs.com, includes Razadyne side effects, interactions and indications.
Zunveyl
Zunveyl (benzgalantamine) is used to treat mild to moderate dementia in Alzheimer's disease (AD) ...
More about Adlarity (donepezil)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: cholinesterase inhibitors
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.